Les cancers colorectaux au cours des maladies inflammatoires chroniques de l’intestin

##plugins.themes.academic_pro.article.sidebar##

Published May 11, 2012
Download
pdf
Vol. 90 No. 5 (2012): Issue May 2012

##plugins.themes.academic_pro.article.main##

Monia Fekih
Lamia Kallel
Nadia Ben Mustapha
Samira Matri
Meriem Serghini
Jalel Boubaker
Azza Filali

##plugins.themes.academic_pro.article.details##

References

  1. Munkholm P. The incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther 2003; 18 (suppl 2): 1- 5.
  2. Van Hogezand RA, Eichhorn RF, Choudry A, Veenendaal RA. Malignancies in inflammatory bowel disease: Fact ou fiction? Scand J Gastroenterol 2002; suppl 236: 48-53.
  3. Lichtenstein GR. Reduction of colorectal cancer risk in patients with Crohn's disease. Reviews in Gastroenterological Disorders 2002; 2 (suppl 2) S16-S24.
  4. Eaden J. The data supporting a role for aminosalicylates in the chemoprevention of colorectal cancer in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2003; 18 (suppl 2): 15-21.